No guarantee of either, but the odds are pretty goood.
Likelihood of FDA acceptance of an NDA for filing - 93.8%
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2775955
Likelihood of FDA marketing approval for orphan drug NDA - 93.6%
![]()
Biotechnology Innovation Organization (BIO): David Thomas; Informa Pharma Intelligence: Daniel Chancellor, Amanda Micklus, Sara LaFever, Michael Hay; QLS: Shomesh Chaudhuri, Robert Bowden, Andrew W. Lo (2021) Clinical Development Success Rates and Contributing Factors 2011–2020
- Forums
- ASX - By Stock
- NEU
- Ann: Acadia submits Rett Syndrome New Drug Application to the FDA
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

Ann: Acadia submits Rett Syndrome New Drug Application to the FDA, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 14.030 |
1 | 500 | 14.000 |
1 | 357 | 13.970 |
1 | 30 | 13.900 |
1 | 700 | 13.700 |
Price($) | Vol. | No. |
---|---|---|
14.260 | 2920 | 1 |
14.300 | 1000 | 1 |
14.380 | 72 | 1 |
14.400 | 1000 | 1 |
14.460 | 434 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online